|
Effectiveness of KOS-862 in the Treatment of Lung Cancer Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Effectiveness of KOS-862 in the Treatment of Lung Cancer conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Effectiveness of KOS-862 in the Treatment of Lung Cancer Clinical research trials and Effectiveness of KOS-862 in the Treatment of Lung Cancer medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Effectiveness of KOS-862 in the Treatment of Lung Cancer. Effectiveness of KOS-862 in the Treatment of Lung Cancer Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Effectiveness of KOS-862 in the Treatment of Lung Cancer clinical trial. Subjects typically recieve the finest healthcare available for their Effectiveness of KOS-862 in the Treatment of Lung Cancer condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Effectiveness of KOS-862 in the Treatment of Lung Cancer  Effectiveness of KOS-862 in the Treatment of Lung Cancer
Effectiveness of KOS-862 in the Treatment of Lung Cancer
For Condition: Lung Cancer
Status: Recruiting
Sponsor(s): Hoffmann-La Roche , Kosan Biosciences
Synopsis: The purpose of this study is to determine whether a potential drug known as KOS-862 or “Epothilone D” has an effect as a 2nd line treatment in non-small cell lung cancer (NSCLC) for patients having failed one prior platinum-containing chemotherapy regimen.
Details: To determine the antitumor activity, based on the confirmed objective response rate, of KOS-862, administered intravenously weekly for 3 weeks every 4 weeks, in patients with non-small cell lung cancer (NSCLC) whose disease has progressed following intitial chemotherapy for advanced or metastatic disease.
Eligibility:
Study Type: Interventional,Treatment,Non-Randomized,Open Label,Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - At least 18 years of age - Measurable disease - One previous treatment of a platinum based drug such as cisplatin or carboplatin - At least 3 weeks since last surgery/radiation/chemotherapy Exclusion Criteria: - Brain metastases - Changes in the rhythm of your heart that are considered significant as determined by an ECG tracing
Total Enrollment: 85
Location and Contact Information:
Memorial Sloan-Kettering Cancer Center *Recruiting*
New York City, New York, 02115
United States
Recruiting Ester Ro 646-227-2187
Saint Francis Memorial Hospital *Recruiting*
San Francisco, California, 94109
United States
Recruiting Mark Jacobs 415-353-6863
Dana-Farber Cancer Institute *Recruiting*
Boston, Massachusetts, 02115
United States
Recruiting Joan Lucca 617-632-5403
Massachusetts General Hospital (MGH) *Recruiting*
Boston, Massachusetts, 02114
United States
Recruiting Allison Brassard 617-726-1849
Ohio State University *Recruiting*
Columbus, Ohio, 43210
United States
Recruiting Tamara Criswell 614-293-7361
University Internal Medicine Associates *Recruiting*
Cincinnati, Ohio, 45267
United States
Recruiting Brandon Kleykamp 513-584-3183
Greater Baltimore Memorical Center (GBMC) *Recruiting*
Baltimore, Maryland, 21204
United States
Recruiting Mechelle Barrick 443-849-8058
Vanderbilt University Medical Center *Recruiting*
Nashville, Tennessee, 37232-5536
United States
Recruiting Teresa Knoop 800-811-8400
Additional Information:
Study ID Numbers: KOS-201/NO17352;
Study Start Date: December 2003
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00080509
Other Lung Cancer Studies:
1. Epoetin alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
2. Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
3. Treating Inoperable Lung Tumors With Heated Chemotherapy Medicine Delivered Solely to the Lung
4. A Phase I Study To Test The Safety Of DAVANAT With and Without 5-Fluorouracil In Patients With Solid Tumors
5. ABX-EGF in Combination with Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
Related Studies:
Other Lung Cancer Clinical Trials
Other Ohio Clinical Trials
Other Cincinnati Clinical Trials
Effectiveness of KOS-862 in the Treatment of Lung Cancer
|
|
|
|
|
|
|
|
